By attenuating NNMT activity, 5Amino1MQ has been observed in preclinical settings to elevate NAD+ availability, enhance metabolic flux, and upregulate downstream signaling programs associated with cellular stress responses and energy expenditure (e.g., SIRT1)
This targeted delivery method allows the peptide to work directly where healing is needed most
In 1989, after more than a decade of work, a Croatian researcher named Predrag Sikiri isolated a molecule he believed was that protector, and named it BPC-157 [1][2]
BPC-157 is so widely available that I doubt any pharmaceutical company would invest in the necessary research to prove or disprove its efficacy and safety, since they are unlikely to gain from it financially
A 2018 review in the International Journal of Molecular Sciences compiled the regenerative-research findings against the backdrop of transcriptomic profiling that flagged thousands of human genes as up- or down-regulated under GHK-Cu exposure (PMID 29986520)